A recent study conducted by Oregon State University has unveiled new insights into how certain polyunsaturated fatty acids, specifically omega 3, combat a severe liver condition. This discovery paves the way for novel drug research for nonalcoholic steatohepatitis (NASH), a disease currently without
A study on omega-3 transporter protein suggests a potential dietary supplement to prevent non-alcoholic fatty liver disease, emphasizing the protective role of phospholipids against liver fat accumulation. Long-running research by Duke-NUS Medical School into the omega-3 transporter protein Mfsd2